Japan Thrombectomy Devices Market Size, Share, and COVID-19 Impact Analysis, By Technology (Mechanical Thrombectomy, Aspiration Thrombectomy, and Rheolytic Thrombectomy), By Utility (Reusable Devices and Disposable Devices), and Japan Thrombectomy Devices Market Insights, Industry Trend, Forecasts to 2033.

Industry: Healthcare

RELEASE DATE Mar 2025
REPORT ID SI9185
PAGES 197
REPORT FORMAT PathSoft

Japan Thrombectomy Devices Market Insights Forecasts to 2033

  • The Japan Thrombectomy Devices Market Size was valued at USD 50.72 Million in 2023.
  • The Market is Growing at a CAGR of 6.30% from 2023 to 2033
  • The Japan Thrombectomy Devices Market Size is Expected to Reach USD 93.40 Million By 2033

 

Japan Thrombectomy Devices Market

Get more details on this report -

Request Free Sample PDF

The Japan Thrombectomy Devices Market Size is Anticipated to reach USD 93.40 Million By 2033, Growing at a CAGR of 6.30% from 2023 to 2033.

Market Overview

Japan thrombectomy devices market focuses on medical devices used to remove blood clots from blood vessels, especially in conditions like stroke or deep vein thrombosis. Key devices include catheters, stent retrievers, and aspiration tools. Japan boasts a well-developed healthcare infrastructure, with major companies like Medtronic, Stryker, and Boston Scientific leading the market in thrombectomy devices. These companies benefit from Japan’s advanced medical research, technological development, and strong healthcare demand. Additionally, the aging population in Japan provides an expanding patient base, while technological advancements in clot retrieval and imaging techniques offer potential for better clinical outcomes. Additionally, Japanese government supports healthcare innovations through initiatives like the Medical Device Development Program, encouraging the development and adoption of new medical technologies. Regulations and reimbursement policies are evolving to support these advancements, which further promotes growth in the thrombectomy devices market.

 

Report Coverage

This research report categorizes the market for the Japan thrombectomy devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan thrombectomy devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan thrombectomy devices market.

 

Japan Thrombectomy Devices Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023:USD 50.72 Million
Forecast Period:2023-2033
Forecast Period CAGR 2023-2033 :6.30%
2033 Value Projection:USD 93.40 Million
Historical Data for:2019-2022
No. of Pages:197
Tables, Charts & Figures:118
Segments covered:By Technology, By Utility and COVID-19 Impact Analysis
Companies covered:: AngioDynamics, Inc, Abbott Laboratories, Penumbra Inc., Johnson and Johnson, Terumo Corporation, Stryker Corporation, Koninklijke Philips N.V., Medtronic plc, Teleflex Incorporated, Boston Scientific Group, and other key vendors.
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

Advancements in minimally invasive medical technologies are driving the adoption of thrombectomy devices, as patients and healthcare providers increasingly prefer procedures with lower risks and faster recovery times. Technological innovations in clot retrieval, imaging techniques, and device efficiency also contribute to market growth by improving patient outcomes and expanding the range of treatable conditions.

 

Restraining Factors

There is a lack of comprehensive awareness and education about these procedures among both patients and healthcare providers, which can impact the demand for thrombectomy devices.

 

Market Segmentation

The Japan thrombectomy devices market share is classified into technology and utility.

  • The mechanical thrombectomy segment accounted for the major revenue share in 2023 and is expected to grow at a remarkable CAGR during the forecast period.

The Japan thrombectomy devices market is segmented by technology into mechanical thrombectomy, aspiration thrombectomy, and rheolytic thrombectomy.  Among these, the mechanical thrombectomy segment accounted for the major revenue share in 2023 and is expected to grow at a remarkable CAGR during the forecast period. The growth in segment is fueled because mechanical thrombectomy involves the use of devices like stent retrievers and thrombectomy catheters to physically remove blood clots from vessels. It is preferred due to its proven effectiveness in treating large vessel occlusions, especially in acute ischemic stroke patients.

 

  • The disposable devices segment accounted for the largest market share in 2023 and is expected to grow at a significant CAGR during the forecast period.

The Japan thrombectomy devices market is segmented by utility into reusable devices and disposable devices. Among these, the disposable devices segment accounted for the largest market share in 2023 and is expected to grow at a significant CAGR during the forecast period. The segment growth is driven because they are convenient, reduce the risk of infections, and are easy to use in emergency situations. Since they are used only once, they ensure sterility for each procedure, which is important in high-risk treatments like stroke.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan thrombectomy devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • AngioDynamics, Inc
  • Abbott Laboratories
  • Penumbra Inc.
  • Johnson and Johnson
  • Terumo Corporation
  • Stryker Corporation
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Teleflex Incorporated
  • Boston Scientific Group
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Recent Developments

  • In January 2025, Penumbra, in collaboration with Asahi Intecc, plans to introduce the Indigo™ Aspiration System in Japan. This system features Lightning™ Intelligent Aspiration technology, which differentiates between clot and blood, minimizing blood loss.

 

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Japan thrombectomy devices market based on the below-mentioned segments

 

Japan Thrombectomy Devices Market, By Technology

  • Mechanical Thrombectomy
  • Aspiration Thrombectomy
  • Rheolytic Thrombectomy

-

Japan Thrombectomy Devices Market, By Utility

  • Reusable Devices
  • Disposable Devices

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies